Log In
Print this Print this

Xomolix, droperidol

  Manage Alerts
Collapse Summary General Information
Company Kyowa Hakko Kirin Co. Ltd.
DescriptionInjectable droperidol
Molecular Target Not applicable
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationEmesis
Indication DetailsTreat and prevent post-operative nausea and vomiting (PONV)
Regulatory Designation
PartnerEndo International plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today